Abstract
Valproic acid concentrations correlate with dose in children when sampling times are consistent. Both interpatient variability and average clearance of valproic acid are inversely related to age. Young children usually need higher doses to achieve the same blood levels as other patients, but the levels that result from a dose are less predictable from one child to the next. Whereas valproic acid therapy had little effect on the serum glutamic oxaloacetic transaminase (SGOT), 12% of patients had abnormal SGOTs during an average of 14 months' therapy. The abnormal SGOTs from patients without serious hepatic dysfunction overlap many of the abnormal values in cases of fatal hepatic failure associated with valproic acid.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
